Niowave, Inc.

Niowave was founded in 2005 by former National Superconducting Cyclotron Laboratory researcher Terry Grimm and a group of private investors. Since then, it has become a worldwide leader in the research, development, manufacturing and operation of superconducting electron linear accelerators as standalone sources and to produce medical and industrial radioisotopes.

Niowave’s highly skilled workforce was built by combining the scientific and technical expertise from nearby world-class universities, national laboratories and the strong manufacturing industry in Michigan. In the company’s state-of-the-art facilities, it produces multiple medical radioisotopes that are used to treat cancer.

This isotope production is achieved by the company’s in-house production, testing and operation of the following:

• Complete accelerator systems and cryomodules
• Accelerating cavities and components
• Electron guns/injectors
• Cryogenic helium refrigerators
• Microwave power sources
• Niobium and niobium alloys

Since 2007, Niowave has performed more than 100 cryogenic tests on more than 25 superconducting cryomodules at its two Lansing, Michigan, facilities.